|
SocialPicks Sentiment:
N/A
** not enough data to be rated
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Extreme FDA Calendar Trades: 21 Stocks Under $5
TRIB
|
|
|
-11.68%
in
140 days
<> Below are extreme trades among 21 companies with stock prices under $5 from the <font> BioMedReports.com FDA Calendar </font> , which includes 264 entries as of 7/20/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submi...
|
FDA Calendar Updates: DDSS, HGSI, OREX, SPPI, TRIB
TRIB
|
|
|
+0.41%
in
7 hours
(closed on 07/20/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 263 entries as of 7/20/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pendin...
|
FDA Calendar Updates: KG, PTIE, DRRX, ALTH, TRIB, CBST, DYAX
TRIB
|
|
|
-0.82%
in
13 days
(closed on 07/20/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 243 entries as of 7/7/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending...
|
FDA Extreme Trades: 16 Stocks Under $5
TRIB
|
|
|
+11.87%
in
10 days
(closed on 07/07/09)
<> Below are FDA extreme trades among 16 companies with stock prices under $5 from the <font> BioMedReports.com FDA Calendar </font> (database includes 225 entries as of 6/27/09) which have pending FDA decisions for either new drug products, biological agents, medical devices, or diagnostic tests that may have a major impact on each of the underlying stock prices. A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in <> <font> Extreme FDA and Clinical Trial Calendar Trade...
|
Bullish on TRIB ...
TRIB
|
|
|
+15.96%
in
179 days
From our FDA Calendar, Trinity Biotech (NASDAQ:TRIB) is up 17.62%? to 3.72 +0.56? as they await two responses from the Food and Drug Administration.
|
From the Blogosphere
Trinity Biotech: Irish Eyes Smiling at Microcap Value
Trinity Biotech (TRIB) is a U.S. listed Irish company which develops, manufactures and sells medical diagnostic products. These products are both laboratory-based tests and point-of-care diagnostics, which are administered and read in the presence of the patient. Its clinical laboratory portfolio includes instruments and assays for diagnosing blood disorders, infectious diseases and diabetes. In the point-of-care market, the company primarily sells tests for diagnosing HIV and other conditions at testing centers, public health facilities, and hospitals. <>Though a small company with approxim...
|
The Long Case for Trinity Biotech
Business Description Trinity Biotech (TRIB) has two distinct segments:
|
Trinity Biotech PLC (TRIB) Diagnosing the Market and Innovating
|
|
|
With headquarters in Bray, Ireland, Trinity Biotech PLC is a company specializing in the development, manufacture, and marketing of clinical diagnostic test kits. Founded in 1992, the company lists on the NASDAQ with a current market capitalization of $73.49M. They market diagnostic systems, including reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. <>Trinity’s products find use in the healthcare industry to detect infectious diseases, autoimmune disorders, and sexually transmitted disease, as well as blood coagulation disorders. Th<><><><><>...
|
Tuesday's 52 week Low's
Tuesday's 52 week Low's
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on TRIB |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About Trinity Biotech plc
- Answers.com
